To include your compound in the COVID-19 Resource Center, submit it here.

Aveo gains on Novartis licensing deal

Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) rose $0.53 (45%) to $1.70 after it granted Novartis AG (NYSE:NVS; SIX:

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE